The innovation accelerator has partnered with the Canadian Cancer Society to create CDL Cancer. The program, which begins in October, will run out of CDL’s Toronto and Vancouver sites, focusing on scaling technologies for cancer detection and care during and after treatment. (The Logic)
Talking point: The partnership adds to CDL’s growing roster of programming spanning nearly 20 streams, including artificial intelligence, agriculture, fintech and energy. The cancer-care initiative, part of CDL’s health and neuro streams, is the most specialized program to date. Like its other cohorts, CDL Cancer will run over nine months, and participating companies will get access to mentorship to hone their business strategies and ideally land investment deals by the end of the program.